Skip to content

The Development of Stuttering in Young Children

Developmental Trajectories to Stuttering Persistence and Recovery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06578416
Enrollment
120
Registered
2024-08-29
Start date
2023-06-01
Completion date
2027-06-01
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stuttering, Stuttering, Childhood, Stuttering, Developmental

Brief summary

The goal of this longitudinal research is to learn why some children "grow out" of stuttering, while others persist. Children who do and do not stutter aged 3-6 years are eligible to participate in our study. During the study, children's speech and language abilities will be assessed with standardized assessments, and they complete several child-friendly experiments. During these experiments, brain activity will be recorded using specialized caps while children describe pictures, children will speak in two virtual-reality scenarios, and produce speech while keeping to a beat.

Detailed description

The length of participation in our study depends on the subset of activities completed. Families in the longitudinal study will take part in three visits each lasting approximately 2 hrs for up to 5 years. Parents and caregivers will complete parent questionnaires (1 x each year for up to 5 years) and a 5-minute, online survey in between visits to the lab (1x each year for up to 5 years). Children will take part in standardized and observational assessments (1x each year for up to 5 years). These may cover aspects of social/emotional development, cognition, and speech, language, and hearing abilities. These tests are used to assess whether a child falls within or outside of the normative range for his/her age. Children will participate in one or more of the following tasks (1x each year for up to 5 years) * Listen to sounds or words and view or name pictures presented on a monitor. Brain activity electroencephalography (EEG) will be recorded while children listen to speech sounds and name pictures. This will be done with an elastic cap that holds special sensors (electrodes). Sensors will also be placed behind each ear, beside each eye, and under the left eye. * Virtual reality (VR). Children wear a VR headset and experience virtual, age-appropriate talking situations (e.g., answering questions in a classroom). While they talk in these scenarios, the headset measures where they are looking (eye tracking), and sensors on their forehead, hand, and finger measure their heart rate and sweat response. * Children will watch cartoons of animals jumping to a consistent beat (rhythm) and produce a word in time with the animal jumping/beat. * Children will repeat nonwords, name pictures, or count while wearing a cap with sensors. Half of the sensors emit light through while the other half measures the reflected light. These sensors give us information about brain activity and are not harmful.

Interventions

DIAGNOSTIC_TESTStandardized assessments of speech and language abilities

Standardized and observational assessment of speech and language abilities

Sponsors

Michigan State University
Lead SponsorOTHER
National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
3 Years to 6 Years
Healthy volunteers
Yes

Inclusion criteria

for controls: * English as first/primary language * No history of neurological disease * Normal or corrected visual acuity * No medications expected to affect performance * No intellectual impairment, autism spectrum disorder, ADHD * Age-appropriate scores on speech and language assessment battery * Pass hearing screening at 20 dB at 500, 1000, 2000, and 4000, bilaterally Inclusion Criteria for children who stutter: * English as first/primary language * No history of neurological disease * Normal or corrected visual acuity * No medications expected to affect performance * No intellectual impairment or ASD Scores on speech and language assessments indicating stuttering, phonological (speech sound), or language disorders * Pass hearing screening at 20 dB at 500, 1000, 2000, and 4000, bilaterally

Design outcomes

Primary

MeasureTime frameDescription
Stuttering Severity1 x each year for up to 5 yearsAssess speech for the presence of stuttering disfluencies and calculate the severity of stuttering based on parent ratings and calculated as the percentage of disfluent syllables out of the total syllables of speech produced.
Virtual reality speaking scenarios1 x each year for up to 5 yearsRecord looking events in msec during virtual reality scenarios (classroom of children and kitten)
EEG recording of event-related brain potentials1 x each year for up to 5 yearsElectroencephalographic (EEG) recordings of event-related brain potentials will be conducted during a picture identification task. ERPs will be averaged across conditions and reported in microvolts.
Speech production synchronization1 x each year for up to 5 yearsWe record productions of a word spoken to the beat under different feedback conditions. We will assess timing measures reflecting the accuracy with which children synchronize their speech to the beat and retain the rhythm.
fNIRS recording of cortical hemodynamic responses1 x each year for up to 5 yearsCerebral hemodynamic responses are recorded during the experiment with a continuous-wave fNIRS system (NIRx, Inc). The system uses LED light source optodes, and avalanche photodiode optode detectors for measuring intensity changes in the diffused light at a 10-Hz sampling rate. The optodes are embedded in a standard EEG cap. The concentrations of oxygenated hemoglobin and deoxygenated hemoglobin in micromols will be calculated across trial intervals as participants describe child-friendly picture scenes. These responses will then be averaged across trials for each child.

Countries

United States

Contacts

CONTACTKatelyn Gerwin, Ph.D.
msustutteringlab@gmail.com5173553410
CONTACTBridget Walsh, Ph.D.
msustutteringlab@gmail.com5173553410

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026